Cancer Drugs Flashcards
1
Q
Anti-metabolite drugs
A
- Folate antagonist
- Methotrexate
- Purine Analogs
- 6-thiopurines
- 6-mercaptopurine
- 6-guanopurine (?)
- Fludarabine ==> CLL tx
- Cladribine ==> HCL tx
- 6-thiopurines
- Pyrimidine Ananologs
- 5-FU
- Capecitabine
- Cytarabine
- Gemcitabine
2
Q
Vinblastine: MOA, SE
A
- MOA:
- inhibits MT formation of mitotic spindle
- SE:
- alopecia
- constipation
- myelosuppression
- neurotoxicity (rare)
3
Q
Cancer drugs that act in the M phase of the cell cycle
A
- vinca alkaloids=inhibit MT fxn/spindle formation
- vincristine
- vinblastine
- paclitaxel
- binds to tubulin and hyperstabilizes MTs that have already polymerized ==> prevents spindle breakdown
4
Q
5-fluorouracil: MOA, use
A
- anti-metabolite
- prevents formation of thymidine vua inhibition of thymidylate synthase
- uses
- slow-growing solid tumors:
- breast
- ovarian
- pancreatic
- colorectal
- gastric carcinomas
5
Q
6-mercaptopurine: MOA, use
A
- anti-metabolite
- inhibits formation of purines
- use = cancer drug
6
Q
Methotrexate: MOA, use
A
- anti-metabolite
- inhibts dihydrofolate reductase ==> inhibition of DNA synthesis (via same pathway as 5-fluorouracil)
- use = cancer drug
7
Q
Busulfan: MOA, use
A
- DNA alkylating agent (cell cyle nonspecific)
- use = CML
8
Q
Bleomycin: MOA, use, SE
A
- inhibit replication by inducing DNA strand breaks via free radical formation
- strand breakage interrupts G2 phase of cell cycle (after DNA synthesis)
- uses: testicular tumors, lymphomas, squamous cell carcinoma
- SE
- rales, cough
- infiltration ==> fibrosis
9
Q
Cyclophosphamide: MOA, uses, SE
A
- DNA alkylating agent (cell cycle nonspecific)
- activated by CYP450
- ==> apoptosis via DNA crosslinking
- uses
- leukemias, lymphomas
- testicular and gyn cancers
- SE
- hemorrhagic cystitis
10
Q
How to prevent major side effect of cycloposphamide
A
- prevent hemorrhagic cystitis via:
- adequate hdration
- IV injection of mesna
11
Q
Methotrexate rescue
A
- folinic acid aka n-formyl-xxxx aka leucovorin
- acts synergystically with 5FU
12
Q
Common method of chemotherapy resistance
A
- human multi-drug resistance gene (MDR1)
- p-glycoprotein = transmembrane ATP-dependent efflux pump
- broad specificity for hydrophobic compounds
- decreases drug entry and increases efflux